Management of Recurrent Pregnancy Loss
Begin a comprehensive diagnostic evaluation after 2 clinically recognized first-trimester pregnancy losses, and implement a systematic, evidence-based approach targeting identifiable causes while providing supportive care for unexplained cases. 1, 2, 3
Initial Diagnostic Workup
Genetic and Chromosomal Testing
- Perform parental karyotyping on both partners to identify chromosomal rearrangements (translocations, inversions) that could cause recurrent losses 1, 2
- Test products of conception when available, as chromosomal errors account for 50-60% of early losses 1
- For patients with recurrent complete hydatidiform moles specifically, order genetic testing for NLRP7 and KHDC3L gene mutations, which cause familial recurrent hydatidiform mole (an autosomal recessive condition) 1, 2, 4
Immunologic Evaluation
- Screen all patients for antiphospholipid antibodies (APLAs) including lupus anticoagulant and anti-cardiolipin antibodies 1, 2
- Do NOT routinely screen for inherited thrombophilias (factor V Leiden, prothrombin G20210A mutation, protein C/S deficiency) as these are not evidence-based causes of RPL 2
- The only exception: women with homozygous factor V Leiden or prothrombin 20210A mutation AND positive family history for VTE should receive antepartum LMWH prophylaxis—but this is for VTE prevention, not pregnancy loss prevention 2, 4
Anatomical Assessment
- Begin with transvaginal ultrasound (TVUS) as the initial screening tool for uterine cavity abnormalities 1, 2, 4
- Proceed to sonohysterography (SIS) for superior assessment of the uterine cavity, as three-dimensional SIS shows 100% accuracy in classifying uterine anomalies compared to hysteroscopy 1, 4
- Hysterosalpingography (HSG) serves as an alternative imaging modality 2
Endocrine and Metabolic Testing
- Measure thyroid function tests (TSH, free T4) as thyroid dysfunction contributes to pregnancy loss and requires optimization before conception 1, 2
- Evaluate for polycystic ovary syndrome (PCOS), which associates with higher pregnancy loss rates 1, 2
- Assess ovarian reserve (AMH levels), as severely diminished ovarian reserve may increase miscarriage risk 1
Male Partner Evaluation
- Evaluate the male partner in ALL couples with ≥2 pregnancy losses—this is now a guideline recommendation 5, 1, 2
- Perform karyotype testing on the male partner to identify chromosomal abnormalities 5, 1, 2
- Consider sperm DNA fragmentation testing, as increasing evidence links elevated sperm DNA fragmentation with recurrent pregnancy loss 5, 1, 2
Treatment Based on Identified Causes
Antiphospholipid Syndrome
- For women meeting laboratory criteria for APLA syndrome, treat with unfractionated heparin or LMWH plus low-dose aspirin 1, 2
- This is the only anticoagulation indication with proven efficacy in RPL 6
Genetic Abnormalities
- Couples with parental chromosomal rearrangements require genetic counseling regarding options including preimplantation genetic testing 1
- Patients with recurrent anembryonic pregnancies due to NLRP7 and KHDC3L gene mutations may benefit from ovum donation rather than conventional IVF 1, 4
Anatomical Abnormalities
- Surgical correction may be appropriate for certain uterine malformations, intrauterine synechiae, or cervical incompetence 1, 3
- History-indicated cerclage should be reserved for individuals with classic historical features of cervical insufficiency or unexplained second-trimester loss in the absence of placental abruption 1
Myeloproliferative Neoplasms (Special Population)
- In low-risk essential thrombocythemia (ET) patients, aspirin therapy alone may be sufficient 5
- High-risk ET or polycythemia vera patients require cytoreductive therapy with pegylated interferon-alpha (45 mcg subcutaneously weekly) plus aspirin throughout pregnancy 5
- Consider interferon-alpha even in low-risk patients with history of recurrent fetal loss, prominent splenomegaly, or suboptimal hematocrit control 5
Lifestyle Modifications
- Counsel on smoking cessation, alcohol avoidance, and elimination of recreational drugs—these are modifiable risk factors 1, 2, 4
- Regular physical activity within guidelines is safe and may actually benefit insulin resistance and obesity, which increase miscarriage risk 1, 2, 4
- Optimize nutrition and maintain healthy weight before attempting conception 1, 2
Management of Subsequent Pregnancies
Early Pregnancy Monitoring
- Confirm viable intrauterine pregnancy with early ultrasound as soon as pregnancy is detected 1, 2, 4
- Provide regular prenatal visits with serial ultrasound monitoring throughout the pregnancy 1, 2, 4
Ongoing Surveillance
- Screen for gestational diabetes in current pregnancies, as glucose intolerance may contribute to pregnancy loss 1, 2, 4
- Monitor for and promptly treat any endocrine conditions, particularly thyroid dysfunction 1, 4
- Consider vaginal progesterone supplementation in patients experiencing first-trimester vaginal bleeding 3
Critical Caveats and Common Pitfalls
What NOT to Do
- There is NO evidence supporting LMWH for prevention of recurrent pregnancy loss outside of confirmed antiphospholipid syndrome 1
- Do not routinely screen for inherited thrombophilias as they are not established causes of RPL 2
- Avoid hydroxyurea and warfarin in women contemplating pregnancy as they are teratogenic 5
Important Definitions
- Anembryonic pregnancies SHOULD be counted when calculating recurrent pregnancy losses for workup purposes, as they represent confirmed early pregnancy losses meeting diagnostic criteria (gestational sac ≥25 mm without an embryo) 4
- RPL is now defined as ≥2 consecutive pregnancy losses, not the traditional 3 losses 3
Prognosis and Counseling
- Most people with RPL, including those without identifiable risk factors, are expected to achieve a live birth within 5 years from initial evaluation 3
- Even with unexplained RPL, subsequent pregnancies have up to 70% chance of success without treatment 6
- Provide compassionate psychological support, as multiple pregnancy losses have significant emotional impact on affected couples 3, 7